Related News:
- Roche’s Actemra/RoActemra receives U.S. FDA…
- FDA approves Roche’s Actemra for the treatment of…
- FDA grants priority review to Xolair (omalizumab)…
- US FDA grants Priority Review to Roche’s Tecentriq…
- WHO grants prequalification of Actemra/RoActemra for…
- WHO grants prequalification of Actemra/RoActemra for…